The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
Rotavirus vaccination was introduced in high-income countries starting in 2006, with no recommendation for optimal implementation. Economic evaluations were presented before launch projecting potential impacts. Few economic reassessments have been reported following reimbursement. This study compare...
Main Author: | Baudouin Standaert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/5/917 |
Similar Items
-
Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
by: Baudouin Standaert, et al.
Published: (2022-02-01) -
Cost-impact study of rotavirus vaccination programme in Scotland
by: R. Heggie, et al.
Published: (2019-06-01) -
Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
by: A.D. Steele, et al.
Published: (2019-06-01) -
Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia
by: Umid Eraliev, et al.
Published: (2021-02-01) -
Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain
by: Alejandro Orrico-Sanchez, et al.
Published: (2017-04-01)